A Newcastle University spinout producing synthetic DNA for biochemical research has announced it has raised £1.9m in seed funding to further its work.
NunaBio, which is based at the Newcastle Helix science and business park, has secured the funds from the North East Innovation Fund, Pioneer Group, Ascension Life Fund and Martlet Capital. The company was founded in April 2021 to develop a novel method of DNA synthesis which enables the speedy and cost-effective production of oligonucleotides – pieces of DNA that can bind to specific molecules – at scale.
NunaBio’s technology can be used in many areas of life sciences, including gene therapy, T cell engineering, diagnostics and targeted biomarker panels. Proceeds will be used to expand the company’s infrastructure to scale-up its existing offering, and to accelerate research and development.
